The O
metabolic O
basis O
of O
cognitive O
insight O
in O
psychosis O
: O
A O
positron O
emission O
tomography O
study O
The O
purpose O
of O
this O
study O
was O
to O
investigate O
the O
relationship O
between O
cognitive O
insight O
and O
cerebral O
metabolism O
in O
patients O
suffering O
from O
psychosis O
. O

The O
Beck O
Cognitive O
Insight O
Scale O
( O
BCIS O
) O
was O
administered O
to O
63 O
patients O
with O
psychosis O
undergoing O
Positron O
Emission O
Tomography O
investigation O
. O

The O
sample O
was O
divided O
into O
two O
groups O
considering O
the O
BCIS O
score O
. O

Data O
were O
analyzed O
using O
Statistical O
Parametric O
Mapping O
. O

Results O
: O
patients O
with O
low O
insight O
, O
compared O
to O
those O
with O
high O
insight O
, O
showed O
decreased O
metabolism O
in O
the O
right O
fusiform O
gyrus O
, O
left O
precuneus O
, O
superior O
temporal O
gyrus O
and O
insula O
bilaterally O
, O
as O
well O
as O
increased O
metabolism O
in O
the O
left O
orbito-frontal O
gyrus O
( O
all O
p O
< O
0.005 O
) O
. O

Our O
results O
suggest O
that O
reduced O
posterior O
( O
occipito-temporo-insulo-parietal O
) O
and O
increased O
anterior O
( O
orbitofrontal O
) O
cerebral O
metabolism O
may O
sustain O
low O
cognitive O
insight O
in O
psychosis O
. O

2 O
. O

Methods O
and O
materials O
2.1 O
Participants O
Sixty-three O
inpatients O
( O
17 O
women O
and O
46 O
men O
) O
, O
aged O
between O
18 O
and O
65 O
years O
, O
with O
acute O
psychosis O
according O
to O
the O
DSM-IV-TR O
( O
APA O
, O
2000 O
) O
criteria O
were O
enrolled O
in O
the O
current O
study O
. O

Thirty-six O
were O
diagnosed O
with O
affective O
psychosis O
( O
all O
with O
bipolar O
disorder O
type O
I O
) O
and O
twenty-seven O
with O
non-affective O
psychosis O
( O
10 O
with O
schizophrenia O
, O
17 O
with O
psychosis O
NOS O
) O
( O
for O
details O
see O
Tables O
1 O
and O
2 O
) O
. O

Exclusion O
criteria O
were O
cognitive O
deterioration O
( O
score O
lower O
than O
24 O
) O
as O
assessed O
by O
the O
Mini-Mental O
State O
Examination O
( O
MMSE O
) O
, O
consistent O
with O
normative O
data O
in O
the O
Italian O
population O
, O
or O
comorbidity O
with O
other O
neurological O
conditions O
involving O
Central O
Nervous O
System O
( O
e.g O
. O

cerebral O
tumors O
) O
and O
pregnancy O
or O
breastfeeding O
. O

The O
study O
was O
approved O
by O
the O
local O
Ethical O
Committee O
( O
Comitato O
Etico O
, O
Fondazione O
“ O
IRCCS O
Ca O
’ O
Granda O
” O
Policlinico O
di O
Milano O
) O
and O
informed O
written O
consent O
was O
obtained O
from O
all O
subjects O
. O

Capacity O
to O
consent O
was O
determined O
through O
clinical O
interview O
and O
MMSE O
, O
in O
order O
to O
assess O
the O
absence O
of O
cognitive O
deterioration O
. O

2.2 O
. O

Clinical O
assessment O
Diagnoses O
were O
conducted O
at O
baseline O
with O
the O
Structured O
Clinical O
Interview O
for O
DSM-IV-TR O
, O
Axis O
I. O
Socio-demographic O
data O
were O
collected O
by O
an O
interview O
completed O
by O
experts O
. O

Clinical O
assessment O
was O
carried O
out O
with O
the O
Brief O
Psychiatric O
Rating O
Scale O
( O
BPRS O
) O
to O
evaluate O
severity O
and O
change O
of O
psychotic O
and O
mood O
symptoms O
. O

Cognitive O
insight O
was O
quantified O
with O
the O
BCIS O
self-report O
inventory O
. O

The O
subscales O
“ O
self-reflectiveness O
” O
( O
formed O
by O
9 O
items O
) O
and O
“ O
self-certainty O
” O
( O
formed O
by O
6 O
items O
) O
are O
defined O
to O
measure O
separate O
aspects O
of O
cognitive O
insight O
. O

They O
rate O
the O
patients O
' O
ability O
to O
observe O
their O
mental O
productions O
and O
to O
reflect O
on O
alternative O
explanations O
and O
overconfidence O
in O
the O
validity O
of O
their O
beliefs O
. O

Accordingly O
, O
among O
psychotic O
patients O
an O
optimal O
cognitive O
insight O
is O
given O
by O
the O
results O
of O
high O
self-reflectiveness O
and O
low O
self-certainty O
; O
a O
composite O
index O
reflecting O
cognitive O
insight O
is O
the O
resulting O
difference O
between O
the O
two O
series O
. O

In O
the O
absence O
of O
cognitive O
insight O
, O
this O
index O
will O
have O
negative O
values O
. O

2.3 O
. O

FDG-PET O
scanning O
FDG-PET O
scanning O
was O
performed O
within O
7 O
days O
of O
insight O
and O
symptom O
assessment O
. O

Patients O
underwent O
FDG-PET O
at O
rest O
, O
after O
intravenous O
injection O
of O
170 O
MBq O
. O

Each O
acquisition O
included O
a O
Computed O
Tomography O
( O
CT O
) O
transmission O
scan O
of O
the O
head O
( O
50mAs O
lasting O
16 O
seconds O
) O
followed O
by O
a O
three-dimensional O
( O
3D O
) O
static O
emission O
of O
15 O
minutes O
using O
a O
Biograph O
Truepoint O
64 O
PET/CT O
scanner O
( O
Siemens O
) O
. O

FDG-PET O
sections O
were O
reconstructed O
using O
an O
iterative O
algorithm O
( O
OS-EM O
) O
, O
corrected O
for O
scatter O
and O
for O
attenuation O
using O
density O
coefficients O
derived O
from O
the O
low O
dose O
CT O
scan O
of O
the O
head O
obtained O
with O
the O
same O
scanner O
, O
with O
the O
proprietary O
software O
. O

Images O
were O
reconstructed O
in O
the O
form O
of O
transaxial O
images O
of O
128×128 O
pixels O
of O
2 O
mm O
, O
using O
an O
iterative O
algorithm O
, O
ordered-subset O
expectation O
maximization O
( O
OSEM O
) O
. O

The O
resolution O
of O
the O
PET O
system O
was O
4–5 O
mm O
FWHM O
. O

2.4 O
. O

Statistical O
analysis O
The O
statistical O
analyses O
were O
performed O
using O
Statistical O
Parametric O
Mapping O
( O
SPM8 O
, O
Wellcome O
Department O
of O
Cognitive O
Neurology O
, O
London O
, O
UK O
) O
. O

FDG O
PET O
data O
were O
subjected O
to O
affine O
and O
nonlinear O
spatial O
normalization O
into O
the O
MNI O
space O
. O

The O
spatially O
normalized O
set O
of O
images O
was O
smoothed O
with O
an O
8mm O
isotropic O
Gaussian O
filter O
to O
blur O
for O
individual O
variations O
in O
gyral O
anatomy O
and O
increase O
the O
signal-to-noise O
ratio O
. O

Images O
were O
globally O
normalized O
to O
50 O
using O
proportional O
scaling O
to O
remove O
confounding O
effects O
to O
global O
cerebral O
glucose O
consumption O
changes O
, O
with O
a O
masking O
threshold O
of O
0.8 O
. O

Subjects O
were O
divided O
into O
four O
groups O
considering O
the O
BCIS O
score O
( O
low O
insight O
with O
R-C O
= O
< O
5 O
and O
high O
insight O
with O
R-C O
> O
5 O
, O
see O
Table O
3 O
) O
and O
the O
diagnosis O
( O
affective O
vs O
non O
affective O
psychosis O
) O
. O

The O
choice O
of O
the O
cut-off O
of O
5 O
to O
divide O
the O
two O
FDG-PET O
groups O
with O
different O
BCIS O
composite O
index O
score O
( O
= O
< O
5 O
and O
> O
5 O
) O
was O
motivated O
by O
the O
average O
value O
( O
4,64 O
) O
shown O
in O
psychotic O
patients O
in O
the O
literature O
, O
similar O
to O
the O
median O
BCIS O
scores O
of O
our O
group O
of O
patients O
. O

We O
performed O
two-sample O
t-test O
between O
the O
low O
and O
the O
high O
insight O
groups O
to O
determine O
if O
the O
data O
were O
significantly O
different O
, O
considering O
P O
values O
< O
0.05 O
as O
statistically O
significant O
. O

We O
found O
no O
statistical O
differences O
between O
the O
two O
groups O
in O
any O
of O
the O
demographic O
or O
clinical O
variables O
employed O
in O
this O
study O
, O
including O
age O
( O
p O
= O
0,335 O
) O
, O
sex O
( O
χ2 O
= O
0,544 O
, O
p O
= O
0,461 O
) O
duration O
of O
illness O
( O
p O
= O
0,123 O
) O
and O
the O
BPRS O
scores O
( O
p O
= O
0,142 O
) O
. O

Finally O
, O
we O
found O
no O
significant O
differences O
between O
the O
two O
groups O
for O
the O
diagnosis O
( O
χ2 O
= O
0,049 O
, O
p O
= O
0,825 O
) O
. O

Significant O
differences O
in O
brain O
metabolism O
among O
the O
four O
groups O
( O
non O
affective O
psychosis O
with O
low O
insight O
, O
non O
affective O
psychosis O
with O
high O
insight O
, O
affective O
psychosis O
with O
low O
insight O
, O
and O
affective O
psychosis O
with O
high O
insight O
) O
were O
estimated O
by O
means O
of O
single-subject O
, O
conditions O
and O
covariates O
design O
, O
with O
the O
4 O
groups O
of O
psychosis O
modeled O
as O
conditions O
, O
with O
insight O
score O
as O
covariate O
variable O
of O
all O
patients O
and O
age O
as O
the O
nuisance O
variable O
for O
group O
analyses O
. O

First O
, O
we O
performed O
a O
one-way O
analysis O
of O
variance O
( O
ANOVA O
) O
between O
the O
four O
groups O
. O

Then O
, O
we O
performed O
two-sample O
t-test O
between O
pair O
of O
groups O
with O
low O
insight O
compared O
to O
those O
with O
high O
insight O
. O

All O
voxel-based O
statistical O
analyses O
of O
brain O
glucose O
metabolism O
images O
were O
performed O
by O
applying O
a O
statistical O
threshold O
of O
uncorrected O
p O
< O
0.005 O
at O
voxel O
level O
for O
F-test O
and O
p O
< O
0.005 O
corrected O
at O
cluster O
level O
for O
t-test O
, O
with O
an O
extent O
threshold O
of O
at O
least O
35 O
contiguous O
voxels O
. O

P O
values O
< O
0.005 O
were O
considered O
statistically O
significant O
in O
analysis O
of O
covariance O
to O
correlate O
the O
cognitive O
insight O
score O
with O
the O
metabolism O
. O

